Pol F. Boudes
2023 - Galectin Therapeutics
In 2023, Pol F. Boudes earned a total compensation of $770.3K as M.D., Former Chief Medical Officer at Galectin Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $160,500 |
|---|---|
| Option Awards | $39,946 |
| Salary | $530,000 |
| Other | $39,834 |
| Total | $770,280 |
Boudes received $530K in salary, accounting for 69% of the total pay in 2023.
Boudes also received $160.5K in bonus, $39.9K in option awards and $39.8K in other compensation.
Rankings
In 2023, Pol F. Boudes' compensation ranked 1,490th out of 2,949 executives tracked by ExecPay. In other words, Boudes earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,490 out of 2,949 | 50th |
Division Manufacturing | 880 out of 1,622 | 46th |
Major group Chemicals And Allied Products | 568 out of 904 | 37th |
Industry group Drugs | 552 out of 867 | 36th |
Industry Pharmaceutical Preparations | 389 out of 625 | 38th |
Source: SEC filing on December 3, 2024.
Boudes' colleagues
We found two more compensation records of executives who worked with Pol F. Boudes at Galectin Therapeutics in 2023.